Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16641 | 578 | 33.5 | 74% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
126 | 23061 | TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//MYCOPHENOLIC ACID |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | POSTTRANSPLANT HYPERLIPIDEMIA | Author keyword | 4 | 75% | 1% | 3 |
2 | ABT LEBENSMITTELSICHERHEIT 1 | Address | 1 | 50% | 0% | 1 |
3 | APOLIPOPROTEIN DISTRIBUTION | Author keyword | 1 | 50% | 0% | 1 |
4 | ATHEROSCLEROTIC CORONARY HEART DISEASE | Author keyword | 1 | 50% | 0% | 1 |
5 | CARDIAC REPLACEMENT | Author keyword | 1 | 50% | 0% | 1 |
6 | DEATH WITH FUNCTIONING GRAFT | Author keyword | 1 | 50% | 0% | 1 |
7 | DIET AND LIPIDS | Author keyword | 1 | 50% | 0% | 1 |
8 | FAMILIAL COMBINED HYPERLIPIDEMIA FCHL | Author keyword | 1 | 50% | 0% | 1 |
9 | HYPERTRIGLYCERIDERMA | Author keyword | 1 | 50% | 0% | 1 |
10 | INSERM U 325 | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PATIENTS RECEIVING CYCLOSPORINE | 9 | 47% | 2% | 14 |
2 | RECEIVING LOVASTATIN | 7 | 29% | 3% | 19 |
3 | LIPID ABNORMALITIES | 5 | 14% | 6% | 33 |
4 | LOW DOSE SIMVASTATIN | 4 | 30% | 2% | 12 |
5 | CHRONIC VASCULAR REJECTION | 3 | 18% | 2% | 14 |
6 | MANAGING DYSLIPIDEMIAS | 2 | 67% | 0% | 2 |
7 | STABLE LIVER | 2 | 67% | 0% | 2 |
8 | POSTTRANSPLANT HYPERLIPIDEMIA | 2 | 43% | 1% | 3 |
9 | CYCLOSPORINE TREATED KIDNEY | 2 | 33% | 1% | 4 |
10 | ALERT TRIAL | 1 | 50% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Hyperlipidemia in solid organ transplantation | 1997 | 190 | 71 | 58% |
HMG CoA reductase inhibitors (statins) for kidney transplant recipients | 2009 | 13 | 56 | 59% |
Statins and solid organ transplantation | 2006 | 23 | 190 | 33% |
HMG CoA reductase inhibitors (statins) for kidney transplant recipients | 2014 | 1 | 91 | 54% |
Calcineurin inhibitors and post-transplant hyperlipidaemias | 2001 | 26 | 88 | 57% |
Cyclosporin A and atherosclerosis - Cellular pathways in atherogenesis | 2010 | 19 | 141 | 12% |
Dyslipidemia and Its Therapeutic Challenges in Renal Transplantation | 2012 | 12 | 47 | 19% |
Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine | 2005 | 27 | 29 | 24% |
Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience | 1999 | 30 | 74 | 38% |
Risk factors for and management of post-transplantation cardiovascular disease | 2001 | 51 | 120 | 28% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ABT LEBENSMITTELSICHERHEIT 1 | 1 | 50% | 0.2% | 1 |
2 | INSERM U 325 | 1 | 50% | 0.2% | 1 |
3 | NEPHROL DIALYSIS INTERNAL MED 3 | 1 | 50% | 0.2% | 1 |
4 | NUCL SCI PL HEATH ICNAS | 1 | 50% | 0.2% | 1 |
5 | OFICINA COORDINAC TRANSPLANTES | 1 | 50% | 0.2% | 1 |
6 | S CARDIOL | 1 | 50% | 0.2% | 1 |
7 | SECT LIPID BIOCHEM | 1 | 50% | 0.2% | 1 |
8 | UNIV CHILDRENS HOSP CRACOW | 1 | 50% | 0.2% | 1 |
9 | UO EMATOL 1CTMO | 1 | 50% | 0.2% | 1 |
10 | DIPARTIMENTI ONCOL | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000210431 | CLIN EXCELLENCE METAB VASC DIS//OBESITY DEGREE//POST TRANSPLANT WEIGHT GAIN |
2 | 0.0000204416 | NEPHROL S 151//ANALBUMINEMIA//IMPAIRED EXERCISE CAPACITY |
3 | 0.0000184101 | POSTTRANSPLANTATION HYPERTENSION//POST TRANSPLANT NEPHROTIC SYNDROME//POST TRANSPLANT HYPERTENSION |
4 | 0.0000183544 | POST TRANSPLANT DIABETES MELLITUS//NODAT//NEW ONSET DIABETES AFTER TRANSPLANTATION |
5 | 0.0000178825 | STEROID WITHDRAWAL//CORTICOSTEROID WITHDRAWAL//EARLY STEROID WITHDRAWAL |
6 | 0.0000173286 | CARDIAC ALLOGRAFT VASCULOPATHY//ALLOGRAFT VASCULOPATHY//GRAFT ARTERIOSCLEROSIS |
7 | 0.0000124252 | SAHLGRENS HOSP CLIN PHYSIOL//CENT HOSP MED 4 UNIONINKATU 38//LIVING RELATED KIDNEY TRANSPLANT |
8 | 0.0000102240 | FK 506//FUJISAWA AMER//FUJISAWA AMER INC |
9 | 0.0000097159 | CARDIOVASC SPECIAL STUDIES//CARDIOVASC EDUC THER EUT CCRE//GEN INTERNAL MED SECT 111A 1 |
10 | 0.0000092484 | SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION//DUAL ORGAN TRANSPLANTATION//COMBINED TRANSPLANTATION |